Get started
Author

Zengkan Du

N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions
2021 · Bingying Du, Yanbo Zhang, et al. · Aging · 38
PDF
Anti-mouse CX3CR1 Antibody Alleviates Cognitive Impairment, Neuronal Loss and Myelin Deficits in an Animal Model of Brain Ischemia
2020 · Bingying Du, Meng Liang, et al. · Neuroscience · 25
Regulatory mechanisms and emerging diagnostic and therapeutic opportunities of non-coding RNAs in tumorigenesis: a pan-cancer perspective
2025 · Doblin Sandai, Zengkan Du, et al. · Critical Reviews in Clinical Laboratory Sciences · 18
RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets
2026 · Xuan Yin, Zengkan Du, et al. · MedComm · 5
Dysregulations of C1QA, C1QB, C1QC and C5AR1 as candidate biomarkers of vascular dementia
2025 · Yawen Xu, Hailing Zhang, et al. · npj Aging · 5
PDF
Intratumoral Microorganisms in Tumors: Current Understanding and Emerging Therapeutic Strategies
2026 · Haoling Zhang, Zengkan Du, et al. · MedComm · 3
Distinct microbial signatures and their predictive value in recurrent acute pancreatitis: insights from 5-region 16S rRNA gene sequencing
2025 · Qi-Wen Wang, Haorui Zheng, et al. · Frontiers in Immunology · 3
RNA editing: an emerging frontier in cancer therapy – explorations, opportunities, and challenges
2026 · Jun Chen, Qi Sun, et al. · International Journal of Surgery · 1
Non-coding RNAs in pancreatitis: from mechanisms to therapeutics
2026 · Zengkan Du, Wenwen Shao, et al. · Molecular Aspects of Medicine
Decoding nucleic acid modification regulatory networks: A key to cancer intervention and treatment
2026 · Qi Sun, Yunxuan Shi, et al. · Physics of Life Reviews
Works count: 11
Citation count: 98
H-index: 5
I10-index: 3
Year
Topic
Type